May 23, 2025
A Nationwide Step Toward Preventive Cancer Care
Metropolis Healthcare Limited has introduced TruHealth Cancer Screen 360, an AI-supported diagnostic initiative focused on early cancer detection. This new offering is designed to address India’s growing cancer burden by shifting the healthcare model from late-stage treatment to proactive screening.
What Does TruHealth Cancer Screen 360 Include?
The comprehensive panel leverages AI-driven analysis to detect a range of cancers at an early stage, improving the chances of timely intervention. The system provides enhanced diagnostic insights, empowering clinicians with data to make more informed decisions.
Expanding Access Across India
By rolling out this offering across Tier 2 and Tier 3 cities, Metropolis ensures equitable access to cutting-edge AI-enabled screening tools. Its vast network of diagnostic centers and home-collection services bridges the healthcare gap for underserved populations.
Expert Support Built In
Along with advanced AI diagnostics, patients also receive follow-up consultations with medical professionals. These sessions help interpret test results and guide appropriate next steps, whether it’s further investigation or reassurance.
Addressing India’s Rising Cancer Burden
As cancer rates increase, early diagnosis remains the most effective way to save lives and reduce healthcare costs. With AI-enhanced capabilities, TruHealth Cancer Screen 360 provides a critical tool to help curb the impact of late-stage detection.
Driving the Future of Diagnostic Innovation
Metropolis is committed to evolving the platform with emerging technologies and medical research. By integrating AI with clinical expertise, the company is setting a new standard in preventive healthcare.
By